explore -WSS

explore

author：Wikipedia 2025-10-02 00:51:47 - browse：3

Sammy Kimball for STAT

Is Wegovy really a brain drug? Which Alzheimer’s disease treatment works best? And what’s the point of Threads?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Megan Molteni joins us to explain the evolving science suggesting products like Wegovy are less weight loss drugs than treatments for human desire. We also explain why this summer is shaping up to be a pivotal moment for the treatment of Alzheimer’s and discuss our befuddlement with the latest social media platform.

For more on what we cover, here’s the story on GLP-1 drugs and the brain; here’s the latest on Leqembi; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： How to keep neuroscience’s past racism from being its future

WSS

Christmas in the PICU brings some surprising joy

Violet CEO on training clinicians to promote more inclusive care

Christmas in the PICU brings some surprising joy

Living with Hashimoto's and celiac disease, and med school, too

Congress must give Medicare recipients genetic counseling access

David Ricks of Eli Lilly: best biopharma CEO of 2023

explore

explore

Wikipedia

Malaria cases in Florida and Texas: Here’s what you need to know

FDA approves first treatment for ultra

In age of alternative facts, a scholarly course on calling out crap

Humana’s Medicare Advantage lawsuit should be tossed, DOJ says

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Majority of Americans think Trump's Ga. election interference case is serious: POLL

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Albert Bourla of Pfizer: worst biopharma CEO of 2023

Anesthesiologist group: stop taking Ozempic before surgery

Patient advocates sound warning on FDA proposal on salt intake

focus

Virtual care provider acquires bankrupt Pear's prescription apps

How to keep neuroscience’s past racism from being its future

Majority of Americans think Trump's Ga. election interference case is serious: POLL

STAT Health News: Apple Watch import ban, Pfizer fumbles, etc

Grail spinoff by Illumina should end disastrous merger attempt

ActiGraph execs on goal of drug approvals with digital endpoints

knowledge

hotspot

knowledge

explore